Exploring the trend in referrals for consideration of CRS and HIPEC to understand the attitudes of clinicians in the development of a national cancer centre programme in peritoneal disease. (4th July 2018)

• Record Type: Journal Article
• Authors: Wang, Weining; Tan, Grace Hwei Ching; Skanthakumar, Thakshayeni; Chia, Claramae Shulyn; Soo, Khee Chee; Teo, Melissa Ching Ching
• Is Part Of: International journal of hyperthermia. Volume 34:Number 5(2018)
• Page Start: 551
• Page End: 558
• Publication Date: 2018-07-04
• Subjects: Referral -- cytoreductive surgery -- hyperthermic intraperitoneal chemotherapy -- peritoneal metastases; Thermotherapy -- Periodicals; 615.832
• DOI: 10.1080/02656736.2017.1387939
• Languages: English
• ISSNs: 0265-6736

Abstract

Abstract: Introduction: Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) improve survival in selected patients with peritoneal metastases. However, only some patients who are potentially eligible for the procedure are considered and referred to the appropriate surgical department. By studying the trends of patients being considered for CRS and HIPEC in our centre, we hope to better understand the demographics of our patient cohort and the attitudes of physicians involved towards CRS and HIPEC. Methods: Patients who were presented and discussed at our institution's multidisciplinary tumour board (MDTB) for consideration of CRS and HIPEC, between 5 January 2011 and 16 December 2015, were identified from the institutional database and included in the study. Patient demographics and clinico-pathological data were retrospectively collected from electronic records and clinical charts. Results: A total of 407 patients were presented at the MDTB for consideration of CRS and HIPEC. Referrals were most commonly from oncology-related departments (65.8%, n = 268). This was followed by referrals from other hospitals (15.0%, n = 61), overseas self-referrals (12.0%, n = 49) and non-oncologic departments within the same institution (7.1%, n = 29). Referrals made by oncology-related departments and overseas self-referrals showed an increasing trend over the years. Of the patients discussed, 197 patients (48.4%) were recommended for CRS and HIPEC, and 134 (68.0%) successfully underwent the procedure. Conclusions: There is growing acceptance of CRS and HIPEC in patients and oncologic-related departments. However, consideration of this procedure as a treatment option remains low in non-oncologic departments. Dissemination of information and well-defined clinical recommendations may help physicians identify and select potentially eligible patients for consideration of CRS and HIPEC.